Safety, immunogenicity, and efficacy of Ad5.F35-GUCY2C-PADRE vaccine in patients with GI cancers at high risk of relapse: Results from a phase 2A trial.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Babar Bashir, Zhengyang Sun, Jagmohan Singh, Daniel Lin, Atrayee B. Mallick, Wei Jiang, Tingting Zhan, Walter K. Kraft, Scott A. Waldman, Adam Snook
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7162529035
Cites:
Cited by:
Related to: